Nirmitee.io Diabetes Care Intelligence

by Nirmitee.io  · Based in United States → — Transforming Healthcare Through Technology
Endocrinology Family Medicine Internal Medicine

Overview

Nirmitee.io Diabetes Care Intelligence is an advanced AI-powered platform designed to revolutionize diabetes management for healthcare providers. This innovative solution integrates continuous glucose monitoring (CGM) data with other critical patient information to provide highly personalized insights and recommendations.

The platform goes beyond simple data aggregation by performing sophisticated analysis of 14-day CGM patterns. It correlates these patterns with key lifestyle factors such as insulin doses, meal timing, and physical activity. This comprehensive analysis allows the AI to identify specific trends and contributing factors to glycemic variability.

A core feature of Nirmitee.io Diabetes Care Intelligence is its ability to generate specific, actionable dosing recommendations. By understanding the intricate interplay between glucose levels, medication, and lifestyle, the platform assists physicians in fine-tuning insulin regimens and other treatment strategies. This leads to more effective diabetes control, reduced patient burden, and improved long-term health outcomes.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • CGM data integration
  • 14-day CGM pattern analysis
  • Correlation with insulin doses, meal timing, and activity
  • Specific dosing recommendations
  • Personalized diabetes insights
  • AI-powered analytics

Use Cases

  • Optimizing insulin regimens for diabetes patients
  • Identifying patterns in glycemic variability
  • Personalizing diabetes care plans
  • Supporting clinical decision-making for endocrinologists
  • Enhancing remote patient monitoring for diabetes

What Physicians Need to Know

Key Capabilities
The platform integrates continuous glucose monitor (CGM) data (from devices like Dexcom G7 and Libre 3), EHR clinical data (via FHIR R4), and patient-logged information (meals, exercise) into a unified diabetes management dashboard. It features AI-powered insulin optimization that analyzes 14-day glucose patterns to recommend dosing adjustments, and population health tools to identify high-risk patients. The system provides a CGM dashboard with a 24-hour glucose trace, event markers for meals, insulin doses, and exercise, along with key metrics like Time in Range, Average Glucose, and Glucose Management Indicator. It also includes an Ambulatory Glucose Profile (AGP) for identifying glucose patterns and alerts for hypo/hyperglycemia.
Clinical Utility
Nirmitee.io's Diabetes Care Intelligence platform has demonstrated significant clinical impact, with an average HbA1c reduction from 8.2% to 6.5% and an increase in time-in-range from 48% to 72% across a patient cohort. This reduction in HbA1c is associated with a 37% reduction in microvascular complications, a 21% reduction in diabetes-related death, and a 14% reduction in myocardial infarction risk. The AI insulin optimization engine's recommendations were accepted by endocrinologists 84% of the time. The platform also supports longitudinal HbA1c tracking and integrated care plans for preventive care requirements.
Integration Options
The platform integrates CGM data streams from manufacturers' APIs (Dexcom/Libre) and EHR clinical data via FHIR R4 (Epic/Cerner). Nirmitee.io specializes in healthcare interoperability, offering integration with various systems and standards including EHR/EMR, Epic, HL7, Mirth Connect, medical devices, FHIR data platforms, and X12 EDI.
Compliance Status
Nirmitee.io emphasizes a 'compliance-first' development approach, ensuring applications satisfy HIPAA, SOC 2, HITRUST, ONC, and international regulations. They claim a 99.9% compliance rate for healthcare apps built. Their methodology embeds regulatory requirements into every phase of development, from requirements and architecture to testing, deployment, and maintenance. They also provide support for health IT certification readiness.
User Experience
The platform aims to provide a unified diabetes management dashboard, addressing the challenge of disconnected data from various sources. It focuses on intuitive user experience and easy-to-use interfaces. The AI recommendations are presented with supporting data to enhance clinician trust and acceptance.
Support Quality
Nirmitee.io highlights a 'Patient-First Approach' and 'Technical Excellence' as core values, aiming for high standards of code quality, security, and performance. They emphasize deep understanding of healthcare workflows and industry-specific challenges.
Implementation Complexity
The platform is designed to merge three previously siloed data streams: CGM data, EHR data, and patient-logged data. Nirmitee.io offers services for healthcare interoperability and custom healthcare software development, suggesting a tailored implementation process to fit specific organizational workflows and existing systems.
Evidence Base
The platform's effectiveness is supported by a case study where it led to a 1.7% average HbA1c reduction and increased time-in-range across 480 patients. These outcomes are linked to significant long-term benefits based on DCCT/UKPDS evidence, including reductions in microvascular complications, diabetes-related death, and myocardial infarction risk. The AI insulin optimization engine's recommendations were accepted by endocrinologists 84% of the time.
Physician Tip

Leverage the unified dashboard to quickly correlate CGM data with medications, meals, and exercise, enabling more informed and timely insulin adjustments. Pay close attention to the AI-powered insulin optimization recommendations, as they are backed by analysis of 14-day glucose patterns and have shown high acceptance rates among endocrinologists. Utilize the population health tools to proactively identify and intervene with high-risk patients before their condition deteriorates. The platform's ability to integrate diverse data streams can significantly reduce the manual effort of reviewing disparate data sources, allowing for more efficient patient management and improved clinical outcomes. Remember that while AI provides powerful recommendations, clinical judgment remains paramount, especially for the 16% of cases where AI recommendations might need modification due to patient-specific factors.

The platform's strength lies in its ability to integrate CGM data from major manufacturers (Dexcom, Libre) and clinical data from EHRs (Epic, Cerner) via FHIR R4. This robust interoperability is crucial for creating a comprehensive patient view. Organizations should ensure their existing EHR systems are capable of FHIR R4 integration to maximize the platform's utility. Nirmitee.io's broader expertise in healthcare interoperability suggests potential for integration with other medical devices, data platforms, and various healthcare IT standards, offering flexibility for future expansion.

Details

Category Endocrinology & Metabolic AI, Pharmacology & Dosing AI, Wearables & Remote Monitoring (RPM)
Pricing Unknown
DeploymentCloud
Mobile AppYes
API Available Yes
Data Export Yes
Training Yes
Compliance
BAA Available Yes AI-estimated
HIPAA Compliant Yes AI-estimated
FDA Status Unknown
SOC 2 Yes AI-estimated
GDPR Yes AI-estimated
Integrations
EHR Not specified
Specialties Endocrinology, Family Medicine, Internal Medicine

Support & Reliability

Training Provided Yes

What the Web Says

Nirmitee.io's Diabetes Care Intelligence platform aims to bridge the gap between continuous glucose monitor (CGM) data and Electronic Health Records (EHR) by integrating various data streams and utilizing AI for insulin optimization and population health management. The platform has shown promising results in improving patient outcomes, such as reducing HbA1c levels and increasing time-in-range. It is designed to provide a unified dashboard for diabetes management, offering AI-powered recommendations for insulin adjustments and identifying high-risk patients.

Overall: Positive

Strengths

  • Integrates CGM, EHR, and patient-logged data into a unified dashboard.
  • AI-powered insulin optimization recommends dosing adjustments based on 14-day glucose patterns.
  • Population health tools identify high-risk patients.
  • Demonstrated improvement in average HbA1c from 8.2% to 6.5% and time-in-range from 48% to 72%.
  • Endocrinologists accepted AI insulin optimization recommendations 84% of the time.
  • Potential to reduce microvascular complications, diabetes-related death, and myocardial infarction risk.

Limitations

  • Limited independent reviews from physicians, healthcare IT, or tech reviewers were found.
  • No specific reviews or discussions found on Reddit, G2, or Capterra for this particular product.
  • Meal logging still requires patient action, with only 60% consistent logging, though photo-based logging improved compliance to 72%.
  • The endocrinologist must still approve AI recommendations, indicating it's a supportive tool rather than fully autonomous.

Based on reviews from: Nirmitee.io, Google Search, G2, Capterra, Reddit, PMC, MedNexus, Trustpilot

Last updated: 2026-09-19

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Nirmitee.io Diabetes Care Intelligence

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Videos

Product demos, reviews, and walkthroughs for Nirmitee.io Diabetes Care Intelligence.

No videos found. Search YouTube directly

View all on YouTube

Frequently Asked Questions

Nirmitee.io's platform integrates CGM data streams (from devices like Dexcom and Libre), EHR clinical data via FHIR R4, and patient-logged information (meals, exercise, insulin doses) into a unified diabetes management dashboard. This allows for a comprehensive view of a patient's diabetes management by correlating all three data streams on a single timeline.
The platform utilizes AI-powered insulin optimization that analyzes 14-day glucose patterns to recommend basal rate and bolus ratio adjustments. The AI provides specific dosing recommendations with supporting data visualizations, but the endocrinologist remains in the loop, always approving recommendations and adding crucial human context like patient preferences or upcoming lifestyle changes.
In a US endocrinology practice, the platform led to an average HbA1c improvement from 8.2% to 6.5% across a patient cohort, a 50% increase in time-in-range (from 48% to 72%), and a 68% reduction in hypoglycemia events. These improvements are associated with significant long-term outcomes, including a 37% reduction in microvascular complications.
Challenges can include inconsistent coding across records, duplicate patient entries, and the sheer volume of data leading to clinician alert fatigue. Nirmitee.io addresses 'black box' concerns by ensuring the AI provides transparent recommendations with supporting data, and emphasizes a 'human-in-the-loop' approach where clinicians always make the final decision.
Nirmitee.io builds its healthcare software with HIPAA compliance and FHIR interoperability standards designed in from day one. They prioritize a patient-first approach, technical excellence, and deep understanding of healthcare workflows and regulations to ensure data security and privacy.
While other digital diabetes management solutions exist, such as those focusing on connected devices (One Drop), personal diabetes assistants (Spike), or non-invasive glucose monitoring (PKvitality), Nirmitee.io differentiates itself by integrating CGM, EHR, and patient-logged data with AI-powered insulin optimization and population health tools, aiming for a unified and intelligent management dashboard.
The provided information does not detail the specific pricing model for Nirmitee.io Diabetes Care Intelligence. For pricing information tailored to different practice sizes or healthcare systems, it would be best to contact Nirmitee.io directly.

Related Tools

SureMediks ProView
SureMediks (Rasimo Systems, LLC)
Clinical Decision Support & Reference
SureMediks is an AI-powered clinical decision support and metabolic health platform that automates care workflows for specialists, providing AI-generated patient summaries, automated chart review, and real-time biometric alerts.
SigXA
SigXA
Documentation & Scribing
SigXA is an AI medical scribe and ambient assistant that transforms patient encounters into structured clinical documentation, specifically tuned for endocrinology teams to manage hormonal and metabolic conditions with protocol-driven longitudinal monitoring.
Wellma for Practitioners
Wellma
Clinical Decision Support & Reference
Wellma for Practitioners is an AI co-pilot that extends care plans between sessions, providing real-time client insights, structured follow-up, and pre-session briefs for metabolic health conditions.
Virta Health
Virta Health
Endocrinology & Metabolic AI
Virta Health offers a virtual health program focused on reversing Type 2 diabetes, prediabetes, and obesity through a nutrition-first approach, continuous remote care, and personalized coaching.
PNOĒ
PNOĒ
Endocrinology & Metabolic AI
PNOĒ is a science-backed cardiometabolic analyzer that performs comprehensive breath-based assessments to measure 23 biomarkers, including VO₂ max, resting metabolic rate (RMR), fat burn efficiency, and biological age. It delivers a 360° snapshot of an individual's physiology by analyzing how oxygen flows through the lungs, heart, and cells. The insights generated are used to personalize nutrition, exercise, and longevity plans.
UpDoc Inc.
UpDoc Inc.
Clinical Decision Support & Reference
UpDoc is an FDA-cleared, enterprise-ready agentic clinical AI platform that integrates with EHRs to deploy AI agents for continuous, physician-governed care-related tasks, especially for chronic disease management.

See all Endocrinology & Metabolic AI tools →

Suggest an Edit → | Report an issue | Last Verified: 2026-09-17 | First Added: 2026-09-17
AI Tool Finder
AI-powered search. Results may not be comprehensive.